Two Hospitals In Gujarat Suspended Over Misuse Of PM-JAY Scheme

Ahmedabad:  Following the Khyati hospital controversy, more cases of misuse of the PM-JAY scheme have come to light in Gujarat. Two more hospitals of the state were suspended over this and a total fine of Rs 3.18 crore has been imposed on them.

The Health Department has started an investigation into hospitals under the PM-JAY scheme. During the investigation, irregularities were found at Krishna Surgical Hospital and Swastik Multi-Specialty Hospital in Rajkot. Additionally, several irregularities were found at Jayaben Modi Hospital in Bharuch and Bankers Super Specialty Hospital in Vadodara.

When the Swastik Multi-Specialty Hospital in Rajkot was investigated, it was revealed that 196 sonography reports had been tampered. As a result, the hospital was suspended from the scheme, and a fine of Rs 2.94 crore was imposed.

Krishna Surgical Hospital in Rajkot was suspended for not having the required building permission and staff. Due to these deficiencies, the hospital was suspended.

In Bharuch, Jayaben Modi Hospital was found to have falsified tumor board certificates by using incorrect signatures and seals, which were then uploaded into the software. As a result, the hospital management has been asked to repay Rs 33,44,031.

At Bankers Super Specialty Hospital in Vadodara, violations of PM-JAY scheme guidelines in oncology surgery were found. A recovery of Rs 57,51,689 will be made from the hospital.

The State Anti-Fraud Unit has intensified its investigations to stop irregularities in private hospitals across Gujarat. Given the ongoing investigations, there is a possibility of further scandals being exposed in the coming days.

Related Posts

  • Pharma
  • May 16, 2025
  • 100 views
Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

US President Donald Trump’s move to slash prescription drug prices by tying them to rates in countries such as the UK and Germany may rattle multinational pharmaceutical giants, but it…

  • Pharma
  • May 16, 2025
  • 96 views
Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix Biopharmaceuticals Ltd in partnership with Canada-based Mantra Pharma Inc—both subsidiaries of Emcure Pharmaceuticals Ltd—has launched Ureaderm 10% and 20%, a new range of urea-based moisturizers designed to address severe dryness…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

DCA seizes syrup stocks over misleading fever cure claim

DCA seizes syrup stocks over misleading fever cure claim

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease